BiomX Inc. Faces Delisting Notice
Ticker: PHGE · Form: 8-K · Filed: Oct 15, 2024 · CIK: 1739174
| Field | Detail |
|---|---|
| Company | Biomx Inc. (PHGE) |
| Form Type | 8-K |
| Filed Date | Oct 15, 2024 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, compliance, regulatory
TL;DR
BiomX got a delisting warning from the exchange, might be in trouble.
AI Summary
BiomX Inc. filed an 8-K on October 15, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company was formerly known as Chardan Healthcare Acquisition Corp. and changed its name on April 30, 2018. The filing indicates potential issues with meeting stock exchange listing requirements.
Why It Matters
This filing signals potential financial distress or non-compliance with exchange rules, which could lead to the stock being delisted, impacting liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a significant risk to investors.
Key Players & Entities
- BiomX Inc. (company) — Registrant
- Chardan Healthcare Acquisition Corp. (company) — Former Company Name
- October 15, 2024 (date) — Date of Report
- April 30, 2018 (date) — Date of Name Change
FAQ
What specific listing rule or standard has BiomX Inc. failed to satisfy?
The filing does not specify the exact rule or standard that BiomX Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is October 15, 2024.
What was BiomX Inc.'s former company name?
BiomX Inc.'s former company name was Chardan Healthcare Acquisition Corp.
When did BiomX Inc. change its name from Chardan Healthcare Acquisition Corp.?
The date of the name change was April 30, 2018.
What is the Commission File Number for BiomX Inc.?
The Commission File Number for BiomX Inc. is 001-38762.
Filing Stats: 523 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-10-15 07:05:07
Key Financial Figures
- $0.0001 — onsisting of one share of Common Stock, $0.0001 par value, and one Warrant PHGE.U N
Filing Documents
- ea0217511-8k_biomx.htm (8-K) — 25KB
- 0001213900-24-087459.txt ( ) — 237KB
- phge-20241015.xsd (EX-101.SCH) — 4KB
- phge-20241015_def.xml (EX-101.DEF) — 26KB
- phge-20241015_lab.xml (EX-101.LAB) — 36KB
- phge-20241015_pre.xml (EX-101.PRE) — 25KB
- ea0217511-8k_biomx_htm.xml (XML) — 6KB
01. Notice of Delisting or Failure to Satisfy a Continued
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard Transfer of Listing. On October 15, 2024, BiomX Inc., or the Company, announced that effective October 25, 2024, the Company's units, which currently trade under the ticker symbol "PHGE.U" will be mandatorily separated and the units will no longer trade on the NYSE American. Each unit consists of one share of the Company's Common Stock, par value $0.0001 per share, or the Common Stock, and one warrant to purchase one-half of a share of Common Stock. In the separation, unit holders will receive shares of Common Stock and warrants underlying their units, which warrants will expire by their terms on October 28, 2024. The Common Stock will continue to trade on NYSE American under the symbol "PHGE" with the other existing shares of the Company's Common Stock. This is a mandatory and automatic separation, and no action is required by the holders of the units. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOMX INC. October 15, 2024 By: /s/ Jonathan Solomon Name: Jonathan Solomon Title: Chief Executive Officer 2